Tcw Group Inc Amgen Inc Transaction History

Tcw Group Inc

$11.2 Billion
Q3 2024

A detailed history of Tcw Group Inc transactions in Amgen Inc stock. As of the latest transaction made, Tcw Group Inc holds 276,727 shares of AMGN stock, worth $79.7 Million. This represents 0.8% of its overall portfolio holdings.

Number of Shares

276,727

Previous 276,727 -0.0%

Holding current value

$79.7 Million

Previous $89.2 Million -0.0%

% of portfolio

0.8%

Previous 0.8%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$309.38 - $337.38 $5.25 Million - $5.73 Million	16,984 Added 6.54%	276,727 $89.2 Million
Q2 2024 Jul 18, 2024	BUY	$262.75 - $319.31 $15.9 Million - $19.3 Million	60,542 Added 30.39%	259,743 $81.2 Million
Q1 2024 May 09, 2024	BUY	$268.87 - $324.56 $6.54 Million - $7.89 Million	24,310 Added 13.9%	199,201 $56.6 Million
Q4 2023 Feb 09, 2024	BUY	$255.7 - $288.46 $8.96 Million - $10.1 Million	35,040 Added 25.06%	174,891 $50.4 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $4.98 Million - $6.18 Million	-22,774 Reduced 14.0%	139,851 $37.6 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $2.63 Million - $3.11 Million	12,294 Added 8.18%	162,625 $36.1 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $1.88 Million - $2.29 Million	8,321 Added 5.86%	150,331 $36.3 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $2.65 Million - $3.37 Million	11,585 Added 8.88%	142,010 $37.3 Million
Q3 2022 Oct 27, 2022	BUY	$224.46 - $253.15 $3.6 Million - $4.06 Million	16,049 Added 14.03%	130,425 $29.4 Million
Q2 2022 Jul 19, 2022	BUY	$230.71 - $256.74 $12.5 Million - $13.9 Million	54,015 Added 89.49%	114,376 $27.8 Million
Q1 2022 Apr 19, 2022	BUY	$219.27 - $242.57 $13.2 Million - $14.6 Million	60,361 New	60,361 $14.6 Million

Others Institutions Holding AMGN

# of Institutions

3,121

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $154B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tcw Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Tcw Group Inc with notifications on news.

Account